Medtronic offers defensive healthcare durability, rising innovation-driven growth, a 49-year dividend-growth record, and meaningful valuation upside despite near-term margin noise.
Overview
Medtronic is a global healthcare technology leader with diversified exposure across cardiovascular, neuroscience, medical surgical, and diabetes markets. The company combines implantable devices, surgical platforms, software-enabled systems, AI-assisted workflows, and recurring consumables. Revenue is geographically balanced, with roughly half from the U.S. and half internationally, improving resilience. Hospitals and clinicians choose Medtronic for clinical evidence, integrated procedural ecosystems, and deep in-room support. Its scale, recurring consumables, and installed base create durable switching costs across critical chronic-care categories.